Cardinal Health stock: Analysts see USD 2.94 EPS before Q1 results

Published on 10/29/2026 at 17:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock approaches its next quarterly test with firm full-year guidance. Investor attention is also turning to recent insider selling.

Cardinal Health vor nächstem Ergebnistest

Analysten erwarten vor dem nächsten Quartalsbericht eine Fortsetzung des Gewinnwachstums.
Die CVS-Vertriebsvereinbarung soll bis 2032 fortgeführt werden.
Insiderverkäufe bilden einen zusätzlichen Beobachtungspunkt für Anleger.

Cardinal Health, US14149Y1082, Illustration mit AI erstellt.

Analysts are setting a new near-term benchmark for Cardinal Health ahead of its fiscal 2027 first-quarter report. In a report published on October 29, 2026, MarketBeat said analysts expect adjusted earnings per share of USD 2.94 and revenue of USD 66.67 billion for the quarter. The figures add a specific test for the company's full-year outlook.

What has changed since our last report

The new estimate is the main incremental development compared with the most recent relevant report. MarketBeat also said insiders sold 210,271 shares worth USD 49.63 million over the past 90 days. That disclosure does not establish a reason for the transactions, but it is a risk-monitoring point alongside the upcoming results.

Guidance remains the reference point

Cardinal Health's October 1 announcement remains the latest company guidance update. In its newsroom release, the company said it had entered a binding letter of intent to extend its existing pharmaceutical distribution agreement with CVS Health through June 30, 2032. Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth of 13 to 15 percent and a range of USD 12.40 to USD 12.60, based on adjusted fiscal 2026 results that exclude the fiscal 2026 IEEPA tariff refund benefit.

The company is scheduled to publish first-quarter fiscal 2027 results before the New York market opens on November 5, 2026, with an investor webcast scheduled for 8:30 a.m. Eastern time. Investors can compare the reported quarter with both the analyst estimate and the reaffirmed full-year range.

Current quote and investor context

Lang & Schwarz quoted Cardinal Health at EUR 223.35 on October 29, 2026, at 16:38 Berlin time. The quote is a euro indication and is not presented as a Xetra closing comparison.

The real-time quote of Cardinal Health stock provides the continuously updated market view.